Location History:
- Cambridge, MA (US) (2019 - 2020)
- North Reading, MA (US) (2023)
Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Robert V Tighe, III
Introduction
Robert V Tighe, III is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of cancer treatment. With a total of 10 patents to his name, Tighe has made remarkable strides in developing methods that utilize antibodies to combat cancer.
Latest Patents
Among his latest patents is a method of treating cancer using CD137 antibodies and PD-1 antagonists. This patent discloses combinations of antibodies that bind to CD137 and PD-1 antagonists, providing a novel approach to treating or ameliorating symptoms of cancer. Another notable patent involves CD137 antibodies and tumor antigen-targeting antibodies, which also aims to treat cancer by administering combinations of these antibodies.
Career Highlights
Tighe's career is marked by his work at Compass Therapeutics LLC, where he has been instrumental in advancing cancer therapies. His innovative approaches have garnered attention in the medical community, highlighting his role as a key player in the fight against cancer.
Collaborations
Tighe has collaborated with notable colleagues such as Ugur Eskiocak and Piotr Bobrowicz, contributing to a dynamic research environment focused on developing effective cancer treatments.
Conclusion
Robert V Tighe, III's work exemplifies the impact of innovation in medical science, particularly in cancer treatment. His patents and collaborations reflect a commitment to improving patient outcomes through advanced therapeutic methods.